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Abstract: 
Thalassemia syndromes are a heterogeneous group of disorders caused by inherited mutations that decrease the 
synthesis of adult haemoglobin, Hb-A [alpha2 beta2]. Depending on whether the genetic defect or deletion lies in 
transmission of alpha or beta globin chain genes, thalassemia are classified in to Alpha and Beta Thalassemia. 
Materials and methods: A Retrospective study was carried out in RIMS Kadapa for two months. Patient 
demographic details, type of thalassemia, prevalence of thalassemia, Hb levels, known & new cases were collected. 
Results: A total of 139 cases were diagnosed as having thalassemia in between February 2017 – March 2017. 
Among which 55 cases were seen in between 11-15 years followed by 6-10 years [38cases] later 0-5 years [38 
cases] , 16-20 years [2 cases] 31-35 years[1case]. Highest number of cases was observed in males [91 cases] than 
females [48]. In our study we couldn't identify type of thalassemia in 122 cases as it was not written in the case 
sheets. Conclusion: There is a urgent need for making the people aware of this threatening disease Thalassemia, as 
this disease increasing day by day in the population silently. Health education programmers in the society may 
reduce the burden of the disease. Moreover, the complications of Thalassemia are one of the major problem on 
which one has to focus. Diagnosis of Thalassemia, treatment in the early phase may reduce the economic burden 
and complications in the society.  
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INTRODUCTION: 
The Thalassemia syndromes are a heterogeneous 
group of disorders caused by inherited mutations that 
decrease the synthesis of adult haemoglobin, HbA 
[alpha2 beta2][1]. It is a single – gene disorder that is 
passed from parents to child by what it is called an 
autosomal recessive pattern of inheritance. It prevents 
the body from synthesis of sufficient quantity of high 
quality of blood. Normally an individual inherits two 
beta globin genes located one each on two 
chromosomes 11, and two alpha globin genes one 
each on two chromosome 16 from each parent. 
Depending on whether the genetic defect or deletion 
lies in transmission of alpha or beta globin chain 
genes, thalassemia are classified in to Alpha and Beta 
Thalassemia. Thus, patients with alpha thalassemia 
have structurally normal alpha globin chains but their 
production is impaired. Similarly, in Beta 
thalassemia, beta globin chains are structurally 
normal but their production is decreased. Each of the 
two main types of thalassemias may occur as major 
or minor. The former is generally assymptomatic 
while the latter is a severe congenital haemolytic 
anemia [2]. The pathophysiology includes, during 
pregnancy, the blood of the foetus contains a special 
kind of haemoglobin, called foetal haemoglobin 
[HbF], made up of one pair of beta chains and one 
pair of Álpha-chains [ gamma 2 Álpha 2]. This 
haemoglobin carries out the same function of 
transporting oxygen around the body that normal 
haemoglobin performs in older children and adults. 
After birth, foetal haemoglobin normally continues to 
function for the first six months of life, when it is 
gradually replaced with adult haemoglobin [HbA], 
made up of two alpha-chains and two beta-chains. In 
thalassaemia major, however, no‚beta-chains are 
produced - or only a very small amount - preventing 
the synthesis of normal adult haemoglobin and 
severely damaging the red blood cells' capacity to 
transport oxygen. The child's body reacts by 
continuing to make foetal haemoglobin. However, it 
cannot make a sufficient quantity to meet the needs 
of the child's growing body and replace the oxygen 
transporting functions of adult haemoglobin alpha 2 
beta 2. Excess alpha chains interfere with the body 
production of RBC, reducing production by up to 
95%.[3] Symptoms includes yellowish colour of skin, 
eyes, pale, fatigue, tachycardia, weak, lethargy, 
irritable. Complications are Osteoporosis, 
Osteopenia, splenomegaly, infections, heart failure, 
endocrine problems like hypothyroidism, 
hypogonadism, growth failure, Diabetes.[4] 
Treatment involves blood transfusion includes only 
250 ml of packed RBC and in order to maintain 
hyperplasic marrow, folic acid supplement is given. 
Prevention and treatment of iron overload is done by 
chelation therapy with desferoxamine and Bone 
marrow transplantation from HLA-matched donar 
that provide stem cells which can form normal 
haemoglobin.[3,5] 
 
METHODOLOGY: 
The present study was a retrospective study carried 
out in the General medicine, ENT, Paediatrics, 
Orthopaedic and Surgery departments medical 
records in Medical record department of Rajiv 
Gandhi Institute of Medical Sciences [RIMS] 
general hospital which is a 750 bedded hospital, 
Cuddapah, south-Indian tertiary care teaching 
hospital of Andhra Pradesh, India for a period of 2 
months [01 February 2017 to 31 march 2017].  
 
A total of 4200 medical records were reviewed in 
our study. Among those, 139 medical records 
regards to thalassemia which were included for 
conducting this study of all age groups and both 
genders with past and present Thalassemia disease 
were included where as thalassemia co-morbid 
conditions were excluded for conducting the study. 
All the records were checked by the clinical 
pharmacist and those who met the study criteria 
were included.  Data required for the present study 
was acquired from the chart review. 
 
Demographic details like [age and sex], type of 
Thalassemia, Prevalence of Thalassemia in different 
blood groups, known and new cases of Thalassemia, 
hemoglobin [Hb] levels, type of treatment received, 
amount of blood transfused were collected. Clinical 
data was studied and analyzed. Data was analyzed 
by descriptive statics. 
 
We observed 122 cases of Alpha Thalassemia, 9 
Major Beta Thalassemia and 8 Beta Thalassemia 
which were represented in the below table no. 04.  
 
RESULTS: 
A total of 139 medical records were enrolled in the 
study. Data was collected based on the inclusion and 
exclusion criteria. Demographic data and clinical 
data was collected and analyzed. 
 
Distribution of thalassemia medical records 
based upon the age: 
A total of 139 medical records were diagnosed as 
having thalassemia in between the period February 
2017 – March 2017. Among those, 11-15 years 
[39.57%] followed by 6-10 years [30.94%] later on 
1-5 years [27.34%], 16-20 years [1.44%] and above 
20 year [0.725%]. We found that average age of the 
patients were 9.123 [±4.507]. It is represented in the 
below table 1. 
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Table 1: Distribution of thalassemia medical records based upon the age and gender 
 
Age Female Male Percentage [%] 
1-5 15 23 27.34 
6-10 13 30 30.94 
11-15 19 36 39.57 
16-20 1 1 1.44 
Above 20 0 1 0.72 
 
Distribution of thalassemia medical records based upon the Gender: 
Among 139 records we found 48 were females [34.53%] and 91 were males [65.46%]. Majority of males is 
higher when compared to females as shown in table 2. 
 
Table 2: Distribution of thalassemia medical records based upon the Gender 
 
Gender No of patients [n=139] Percentage [%] 
Female 48 34.53 
Male 91 65.46 
 
Distribution of thalassemia medical records based on the weight: 
Among 139 records, we observed that majority of the patient’s weight is in between 11-20 kgs followed by 21-
30kgs later on 0-10kgs, 31-40kgs, 41-50kgs and 51-60kgs. We found that the average weight of the patients 
along with standard deviation was 21.087[±9.012]. It is represented in the table 3. 
 
Table 3: Distribution of thalassemia medical records based on the weight 
 
Weight No of patients 
0-10 12 
11-20 60 
21-30 52 
31-40 11 
41-50 2 
51-60 1 
  
Distribution of thalassemia medical records based upon the Type of Thalassemia: 
In our study we could not able to identify type of thalassemia in 122 cases as it was not mentioned in case 
sheets, we found 9 thalassemia cases and 8 major cases as represented in the Table 3. 
 
Table 4: Distribution of thalassemia medical records based upon the Type of thalassemia 
 
Age 
[years] 
Beta-T 
Total 
Major Beta- T Alpha-T  Grand Total 
1-5 4 2 32 38 
6-10 4 4 35 43 
11-15 1 1 53 55 
16-20 0 1 1 2 
31-36 0 0 1 1 
Total 9 8 122 139 
 
 
   
IAJPS 2017, 4 (12), 4365-4369                         . Lavanya et al                          ISSN 2349-7750 
 
w w w . i a j p s . c o m  
 
Page 4368 
Distribution of thalassemia medical records based on the history: 
69.07% records were newly diagnosed whereas 30.93% records were known case of thalassemia. It is 
represented in table .4. 
 
Table 5: Distribution of thalassemia medical records based on the history 
 
Past History Female Male Grand Total Percentage  
Known 12 31 43 30.93 
New 36 60 96 69.07 
 OF PATIENTS BASED ON HISTORY 
Distribution of thalassemia medical records based on the Haemoglobin level: 
The hemoglobin level was 3-4.9 in 07.93%, 5-6.9 in 40.28% and 7-8.9 in 47.48% the remaining above 8.9 in 
04.31% was as shown in the table 1.5. Majority of the patients was seen with Hb level 7-8.9 in 66 records 
followed by 5-6.9 in 56 records and 3-4.9 in 11 records. We found that average levels of Hb were 6.718 
[±1.388]. 
 
Table 6: Distribution of thalassemia medical records based on the haemoglobin level 
 
Haemoglobin levels [gm/dl] No. of medical records Percentage [%] 
Less than 3 0 0 
03 - 4.9 11 07.91 
05 - 6.9 56 40.28 
07 - 8.9 66 47.48 
9 & above 6 04.31 
Total 139 100 
 
 
DISCUSSION: 
Thalassemia is the genetic disorder occur primarily 
due to defective formation of globin chain of the 
hemoglobin moiety of the RBC. It is a specific type of 
blood disease which results in consequences of 
excessive destruction of red blood cells which in turn 
leads to anemia. In this, RBC breakdown occur at an 
early stage due to abnormal globin chain unable to 
protect RBC in oxidative stress. Ultimately, resulting 
in destruction of RBC. In thalassemia the rate of 
destruction of RBC is so rapid that it exceeds the liver 
capacity to metabolize the excess billirubin. 
Thalassemia is a major health problem, and 
approximately 1 in 14 of the population is carriers for 
one of the sub types. 
 
As it is a retrospective study, our study focuses on the 
prevalence of Thalassemia and their types in the 
population. In our study 139 thalassemia medical 
records were enrolled in that 48 were females and 91 
were males. Our study reveals the actual rate of the 
population suffering from Thalassemia is male and the 
incidence of male population is higher. In this study, 
we categorized the patients according to their age 
groups and found that the majority of the patients 
suffering from Thalassemia are in the 11-15 years age 
group. CK Li, CW Luk et al., also reported that 
majority of patients with thalassemia are in age group 
of 11-20 years. In our study population the patients 
came with known history of Thalassemia is more 
when compared to the new cases. Health education is 
important in both patients as there is a chance of 
getting Thalassemia to their children. It requires 
proper disease and treatment education and adequate 
knowledge regarding their lifestyle modifications to 
overcome the situation in the family or community. In 
our study, we found majority of the patients are with 
hb levels lower than 9 i.e., 95.69%. Abdolreza 
Rajaeefard et al., also concluded that majority of the 
patients are with below 9 Hb levels. We distinguished 
the thalassemia medical records based on the type of 
Thalassemia and found that patients suffering from 
beta thalassemia type are more. Educating the person 
about types of Thalassemia is much more important as 
this type also leads to anemia. Complications of 
Thalassemia and blood transfusion compatibilities 
must be understood by every individual. 
 
CONCLUSION: 
There is an urgent need for making the people aware 
of this threatening disease Thalassemia, as this disease 
is mounting day by day in the population silently. 
Health education programmers in the society may 
diminish the burden of the disease. Moreover, the 
complications of Thalassaemia are one of the foremost 
problem on which one has to be focus on diagnosis of 
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Thalassemia, treatment in the early phase may reduce 
the economic burden and complications in the society. 
We observed Thalassemia majorly in the pediatrics. 
Hence, it is important to provide patient counseling by 
the clinical pharmacist to the parents and the 
individuals for better health care. 
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